Abstract
The work presented herein outlines the ongoing structure-activity relationship (SAR) studies centered around a potent, efficacious, and selective positive allosteric modulators (PAM) of the GIRK1/2 channel. Optimization studies centered around the pyrazole privileged scaffold, the N-1-position of the pyrazole and the right-hand ether. The work confirmed the necessity of the pyrazole, and we have identified a more potent GIRK1/2 activator with ~12-fold selectivity against GIRK1/4. We also report the metabolite ID study which shows the instability of the amide bond as the major site of metabolism (non-NADPH mediated). This work discovered another highly potent and selective GIRK1/2 activator for use as an in vitro tool compound.
Supplementary materials
Title
Chemical characterization and NMR spectra
Description
Synthesis and characterization of intermediates and 1H and 13C spectra of final compounds.
Actions